Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $1.288B (100.0% shares, 0.0% debt)

Holdings (24)

BN BROOKFIELD CORP 12.5%
Value $160M Shares 3,496,245 Est. Cost $29.96 Unrealized +52.0%
EWTX EDGEWISE THERAPEUTICS INC 10.3%
Value $133M Shares 5,350,000 Est. Cost $18.02 Unrealized +11.4%
ASML ASML HOLDING N V 9.5%
Value $122M Shares 113,946 Est. Cost $662.32 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 7.8%
Value $99.85M Shares 1,264,028 Est. Cost $12.27 Unrealized +485.2%
CRM SALESFORCE INC 6.8%
Value $87.47M Shares 330,187 Est. Cost $205.72 Unrealized +20.6%
CRNX CRINETICS PHARMACEUTICALS IN 5.9%
Value $75.64M Shares 1,625,000 Est. Cost $25.38 Unrealized +75.4%
VRDN VIRIDIAN THERAPEUTICS INC 5.8%
Value $74.07M Shares 2,380,000 Est. Cost $16.63 Unrealized +64.9%
MPLT MAPLIGHT THERAPEUTICS INC 5.0%
Value $64.76M Shares 3,686,622 Est. Cost $16.75 Unrealized 0.0%
ZBIO ZENAS BIOPHARMA INC 4.1%
Value $52.65M Shares 1,450,000 Est. Cost $14.60 Unrealized +125.3%
PHVS PHARVARIS N V 3.8%
Value $48.56M Shares 1,750,000 Est. Cost $15.36 Unrealized +56.8%
APGE APOGEE THERAPEUTICS INC 3.3%
Value $43.02M Shares 570,000 Est. Cost $41.12 Unrealized +53.2%
PCVX VAXCYTE INC 3.3%
Value $42.27M Shares 916,160 Est. Cost $39.88 Unrealized +12.1%
BMRN BIOMARIN PHARMACEUTICAL INC 3.0%
Value $39.22M Shares 660,000 Est. Cost $77.70 Unrealized -29.9%
AVBP ARRIVENT BIOPHARMA INC 3.0%
Value $39.08M Shares 1,942,142 Est. Cost $20.49 Unrealized +1.6%
BABA ALIBABA GROUP HLDG LTD 2.9%
Value $37.72M Shares 257,327 Est. Cost $165.09 Unrealized
INSM INSMED INC 2.7%
Value $34.81M Shares 200,000 Est. Cost $23.10 Unrealized +689.9%
CLDX CELLDEX THERAPEUTICS INC NEW 2.5%
Value $32.59M Shares 1,200,000 Est. Cost $34.88 Unrealized -24.5%
FDMT 4D MOLECULAR THERAPEUTICS IN 2.1%
Value $27.38M Shares 3,650,737 Est. Cost $12.43 Unrealized -18.4%
BBOT BRIDGEBIO ONCOLOGY THERAPEUT 1.9%
Value $24.56M Shares 1,961,317 Est. Cost $11.58 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 1.8%
Value $22.79M Shares 1,480,000 Est. Cost $19.25 Unrealized +3.5%
VALN VALNEVA SE 1.6%
Value $20.33M Shares 2,305,000 Est. Cost $5.67 Unrealized
LNZA LANZATECH GLOBAL INC 0.2%
Value $2.176M Shares 158,148 Est. Cost $28.70 Unrealized -34.8%
MQ MARQETA INC 0.2%
Value $2.097M Shares 441,558 Est. Cost $22.37 Unrealized -78.5%
IOBT IO BIOTECH INC 0.1%
Value $1.53M Shares 2,512,453 Est. Cost $6.26 Unrealized -88.1%